HealthStream (NASDAQ:HSTM) Price Target Raised to $32.00

HealthStream (NASDAQ:HSTM) had its price target hoisted by Canaccord Genuity Group from $29.00 to $32.00 in a research note released on Wednesday,Benzinga reports. The firm currently has a hold rating on the technology company’s stock.

A number of other equities analysts have also recently commented on HSTM. Wall Street Zen raised shares of HealthStream from a “hold” rating to a “buy” rating in a research note on Saturday, October 31st. Citigroup reissued a “market perform” rating on shares of HealthStream in a research report on Tuesday, October 27th. Weiss Ratings raised shares of HealthStream from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Craig Hallum lowered HealthStream from a “buy” rating to a “hold” rating and set a $40.00 target price for the company. in a research report on Tuesday. Finally, Freedom Capital upgraded HealthStream to a “hold” rating in a research report on Tuesday, October 13th. One analyst has rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, HealthStream currently has a consensus rating of “Hold” and an average price target of $36.00.

HealthStream Stock Down 2.4%

HSTM traded down $0.71 during trading on Wednesday, reaching $28.89. The company had a trading volume of 249,732 shares, compared to its average volume of 188,233. The stock has a market cap of $844.17 million, a P/E ratio of 41.27, a PEG ratio of 4.00 and a beta of 0.45. The business has a 50 day simple moving average of $31.20 and a 200-day simple moving average of $25.83. HealthStream has a 52 week low of $19.50 and a 52 week high of $35.60.

HealthStream (NASDAQ:HSTM) last posted its quarterly earnings data on Monday, November 2nd. The technology company reported $0.18 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.02. HealthStream had a net margin of 6.25% and a return on equity of 6.58%. The business had revenue of $83.31 million for the quarter, compared to analysts’ expectations of $82.24 million. As a group, equities research analysts expect that HealthStream will post 0.80 EPS for the current fiscal year.

HealthStream Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 27th. Stockholders of record on Monday, November 16th will be paid a dividend of $0.0350 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Monday, November 16th. HealthStream’s payout ratio is currently 20.00%.

Insider Activity

In other HealthStream news, EVP Michael Manning Collier sold 21,300 shares of the business’s stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $29.97, for a total value of $638,361.00. Following the completion of the sale, the executive vice president directly owned 59,260 shares of the company’s stock, valued at $1,776,022.20. The trade was a 26.44% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Kevin P. O’hara sold 4,000 shares of the company’s stock in a transaction dated Thursday, November 5th. The stock was sold at an average price of $31.11, for a total transaction of $124,440.00. Following the completion of the transaction, the executive vice president owned 18,901 shares in the company, valued at $588,010.11. This represents a 17.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 194,149 shares of company stock valued at $5,844,892. Insiders own 20.40% of the company’s stock.

Hedge Funds Weigh In On HealthStream

Institutional investors have recently modified their holdings of the stock. BlackRock Inc. bought a new stake in shares of HealthStream during the second quarter valued at approximately $111,184,000. Dimensional Fund Advisors LP grew its stake in HealthStream by 6.4% in the first quarter. Dimensional Fund Advisors LP now owns 1,456,043 shares of the technology company’s stock worth $30,156,000 after purchasing an additional 87,177 shares in the last quarter. Copeland Capital Management LLC grew its stake in HealthStream by 43.8% in the first quarter. Copeland Capital Management LLC now owns 1,276,739 shares of the technology company’s stock worth $26,441,000 after purchasing an additional 389,186 shares in the last quarter. Renaissance Technologies LLC grew its stake in HealthStream by 0.5% in the first quarter. Renaissance Technologies LLC now owns 477,848 shares of the technology company’s stock worth $9,896,000 after purchasing an additional 2,380 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its holdings in HealthStream by 21.1% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 377,945 shares of the technology company’s stock worth $7,827,000 after purchasing an additional 65,806 shares during the period. 69.58% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting HealthStream

Here are the key news stories impacting HealthStream this week:

• Positive Sentiment: Buy rating upgrade: Zacks upgraded HSTM to Rank #2 (Buy), citing improving earnings prospects, which could support investor optimism. Zacks article
• Positive Sentiment: Raised guidance: HealthStream lifted its outlook, a potentially positive sign for expected business performance, although the article raises the question of whether prior gains already reflect the news. Yahoo Finance article
• Neutral Sentiment: Analyst views remain cautious: Canaccord Genuity raised its price target to $32 from $29 but maintained a Hold rating; Craig Hallum also moved its rating to Hold. These calls suggest limited conviction despite the higher target. Canaccord rating information Craig Hallum rating article
• Negative Sentiment: Multiple insider sales: On November 5, EVP Michael Manning Collier, CFO Scott Alexander Roberts, Director Deborah Tate and EVP Kevin O’Hara sold a combined 38,081 shares. Each reduced their individual holdings, a cluster of transactions that may weigh on sentiment, though insider sales alone do not establish a change in the company’s outlook. Collier SEC filing Roberts SEC filing Tate SEC filing O’Hara SEC filing

About HealthStream

HealthStream, Inc provides workforce and provider solutions designed for healthcare organizations. Its software and services help hospitals, health systems, medical practices and other healthcare providers manage employee education, training, credentialing, compliance and professional development.

The company’s offerings include learning management and education tools, competency and performance-management solutions, and systems for managing provider credentials, privileging and enrollment.